Tenderwize
Back to tender search

Open-house discount agreements for Naproxen

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Sep 05, 2026 · 19 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Naproxen, ATC M01AE02

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

46 / 100

Complexity

58 / 100

Risk factors

For paper submissions, advance fax/scan/email transmission is only deadline-preserving if the original paper documents...

Only pharmaceutical companies are eligible as potential contract partners.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Oct 2026
  • Non-exclusive open-house discount agreements for pharmaceutical products concerning Naproxen, ATC M01AE02.
  • Supply contract model for a medicinal product discount agreement under § 130a(8) SGB V, as described in the notice.
Show full summary

Open-house supply arrangement for Naproxen (ATC M01AE02) offered by AOK Bayern to all interested pharmaceutical companies that meet the stated suitability requirement. This is explicitly described as a non-exclusive, non-negotiated accession model, not a classic competitive award procedure. No contract value is stated. Submission is possible electronically with a qualified electronic signature or in paper form, with strict monthly cut-off rules and a final deadline of 05.09.2026.

Risks

For paper submissions, advance fax/scan/email transmission is only deadline-preserving if the original paper documents...

Only pharmaceutical companies are eligible as potential contract partners.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The signatory's authority must be evidenced by the commercial register extract; otherwise a power of attorney must be provided.

Administrative

  • Submit a signed contract, the completed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and the signed declaration of reliability.
  • Submissions must be either handwritten on paper or electronically with a qualified electronic signature.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house discount agreements for Naproxen

Single lot covering non-exclusive open-house pharmaceutical discount agreements for the active substance Naproxen (ATC M01AE02). The lot is for supplies and performance is in Germany, Bavaria (DE212). The notice states that all interested pharmaceutical companies meeting the suitability requirement may join on identical terms. Lot information comes from structured data and notice text.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Oct 2024 - Oct 2026

Category

Pharmaceutical products

Deadline

Deadline Sep 05, 2026

Procurement Details

Publication date
16 Sep 2024
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
558157-2024

Documents (2)

Similar tenders